Skip to content

NCI R25 Courses Skills Development Eligibility Guide

Updated 8 official sources

Quick Answer: PAR-23-276 no longer accepts applications. NCI expired it early on June 18, 2026 under NOT-CA-26-017 (opens in a new tab), along with its sister notices PAR-23-277 and PAR-23-278.

Full answer and how we checked it

NCI now sends course applications to the parent R25, PA-27-034 (opens in a new tab), which opened August 25, 2026, has its next due date on January 25, 2027, and expires May 26, 2029. The 7 fit checks below still apply: course model, cancer research skills fit, launch readiness, participant definition, evaluation plan, clinical trial not allowed status, and route fit.

Who this is for: Cancer center educators, training program leaders, course directors, research deans, oncology departments, education offices, and sponsored-research teams deciding whether an NCI R25 course route fits.

Data note: This guide uses NIH PAR-23-276 (opens in a new tab), NCI R25 funding pages (opens in a new tab), NCI R25 course examples (opens in a new tab), Grants.gov listing 350415 (opens in a new tab), and Grantsights award-data signals checked on June 2, 2026, rechecked against NIH notices and NIH RePORTER (opens in a new tab) on October 9, 2026.

In this guide

Quick Facts

Agency
HHS
Deadline on record
Jan 7, 2027 (notice closed)
Status
Closed

Assistance Listing 93.398: all awards

Source: USASpending.gov FY2024

These figures cover all National Institutes of Health awards under Assistance Listing 93.398, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.

Total Awards (FY2024, whole listing)
2,179
Avg Award (whole listing)
$1,021,124
Median Award (whole listing)
$344,088
Total Funding (FY2024, whole listing)
$216.8M
YoY Funding Trend
+2%

Data last verified: May 22, 2026

According to NIH in PAR-23-276 (opens in a new tab), this R25 supports research educational activities that complement formal training programs and build a workforce for biomedical, behavioral, and clinical research needs. For NCI, the course must connect to cancer research.

The decision question is whether the project is a course for skills development, not a research study, not a conference, and not a curriculum-development project that will not be ready to operate.

Use this guide with the live NCI R25 Courses program record. Then compare NIH grants complete guide, what is a NOFO, NCI K99 Clinical Trial Required guide, NCI K99 Clinical Trial Not Allowed guide, NCI Cancer Center Support Grants P30 guide, and the Grantsights grant database.

October 2026 Status: PAR-23-276 Expired, PA-27-034 Replaces It

PAR-23-276 was scheduled to run through January 8, 2027, but NOT-CA-26-017 (opens in a new tab) expired it, PAR-23-277 (research experiences), and PAR-23-278 (curriculum or methods development) effective June 18, 2026. The September 25, 2026 date listed in PAR-23-276 never happened under that notice. NCI's R25 award page (opens in a new tab) now lists 3 parent NIH R25 notices for its cancer research education program, and courses fall under PA-27-034, "Courses, Curriculum & Methods."

PA-27-034 factWhat the notice and NCI say
Open dateAugust 25, 2026
Due datesSeptember 25, 2026 (passed); January 25, 2027; May 25, 2027; then the standard January, May, and September 25 cycle
ExpirationMay 26, 2029
NCI course budgetUp to $300,000 direct costs per year for up to 5 years
NCI curriculum or methods budgetUp to $150,000 direct costs per year for up to 2 years
Indirect costs8% of modified total direct costs
Clinical trialsNot allowed
Review for January 25, 2027July 2027 review, October 2027 council, December 2027 earliest start

The course rules carried over in substance. NCI's page still says the course must be offered in each year R25 support is requested, and that a team needing year one for development should propose curriculum or methods development instead. PAR-23-276 also required all instructional activities to finish within a 12-month period. Because PA-27-034 is a trans-NIH parent notice, its general text says budgets typically run no more than $500,000 direct costs, but NCI's own page sets the lower $300,000 course ceiling, so plan to that number.

What NCI Funded Under PAR-23-276

About 20 distinct projects show up under PAR-23-276 in a NIH RePORTER (opens in a new tab) pull Grantsights ran on October 9, 2026 (30 project-year records in FY2025 and FY2026). Grantsights analysis of those records shows yearly direct costs from about $99,700 to $303,800, with most new awards between $180,000 and $304,000.

AwardOrganizationCourse
R25CA298916Cold Spring Harbor LaboratoryMethods in Cancer Neuroscience
R25CA174664American Association for Cancer ResearchIntegrative Molecular Epidemiology Workshop (renewal, year 12)
R25CA306814University of MinnesotaBiomarker development for cancer prevention
R25CA314622City of Hope (Beckman Research Institute)Clinical trials nursing education
R25CA302442Wake Forest University Health SciencesQualitative Training Institute for cancer research

Three patterns stand out. Several awards are long-running renewals, which NCI allows for courses (the AACR workshop and the Dana-Farber supportive oncology methods workshop are both in year 11 or later). Many funded courses target clinicians and allied professionals, such as social workers, nurses, and palliative care teams, not only PhD scientists. And research methods courses, from qualitative methods to implementation science, appear as often as wet-lab techniques.

7 PAR-23-276 Eligibility Stop Checks

Stop checkStrong R25 signalRed flag
Course modelCourse, workshop, or short course is centralResearch project in disguise
Cancer fitSkills support cancer research workforceGeneral education only
TimelineCourse can operate earlyDevelopment delays launch
ParticipantsAudience and selection are clearAudience is vague
EvaluationLearning outcomes and metrics are definedSatisfaction survey only
Trial statusNo clinical trialHuman intervention study
Route fitR25 is better than T, K, R, or conference routeWrong mechanism

An R25 education idea can be useful while the mechanism fit is weak. The issue is usually that the project is not course-centered enough.

5 Source Facts Applicants Should Know

According to NIH in PAR-23-276 (opens in a new tab), the funding number is PAR-23-276, the mechanism is R25, clinical trials are not allowed, and courses for skills development are the supported activity. According to NCI's R25 award page (opens in a new tab), the program supports educational activities that build the cancer research workforce.

According to NCI's R25 course examples (opens in a new tab), funded courses include cancer research education programs across clinical, data, communication, supportive care, and other cancer-relevant areas. According to USAspending.gov (opens in a new tab) data, the connected assistance listing (93.398) had about $216.8M in FY2024 obligations across 2,179 awards active that year.

FactSource-backed read
Funding numberPAR-23-276
MechanismR25 research education
Clinical trial statusNot allowed
Program focusCancer research skills courses
Next standard dateNone; the September 25, 2026 date was canceled when the notice expired
Budget cap$300,000 direct costs per year
Expiration dateJune 18, 2026, early under NOT-CA-26-017 (opens in a new tab) (originally January 8, 2027)

What NCI Doesn't Tell You

Within 21 days, answer 4 practical questions. First, an R25 course is not a training grant. It can complement formal training, but it does not replace T32, K, or fellowship support.

Second, participants matter. For example, a center building a short course on cancer data science would need to define learner stage, selection, prerequisites, mentoring touchpoints, and skill assessment. PAR-23-276 also expected participants to come from a regional or national pool beyond the applicant institution.

Third, if course development would prevent launch in year one, NIH points applicants toward companion curriculum or methods development routes. Don't use the courses route for a course that is not ready to run.

Fourth, participant support rules are delicate. Individuals supported by K, T, or F mechanisms may receive educational experiences through an R25, but salary or stipend supplementation is restricted.

According to NCI, courses for skills development should provide evidence-based cancer research education derived from biomedical, behavioral, and clinical cancer research findings. According to NIH PAR-23-276 and NCI's current R25 page, if course development would prevent the course from running in year 1, the companion curriculum or methods development route may be better. If the project is mainly research, a conference, or an undeveloped course concept, skip this route before writing the budget.

6 Evidence Assets That Make This R25 Stronger

Within 21 days, build 6 evidence assets. Asset 1 is a course logic model. Include audience, skills, activities, faculty, products, and outcomes.

Asset 2 is a participant plan. Include eligibility, recruitment, selection, cohort size, accessibility, and expected research role.

Asset 3 is the curriculum map. Tie modules to cancer research skill gaps and learning outcomes.

Asset 4 is an evaluation plan. Include pre/post measures, product review, skill demonstration, follow-up, and career or research outputs.

Asset 5 is a faculty and operations plan. Courses fail when faculty roles, time, platform, and logistics are vague.

Asset 6 is the route comparison. Compare courses, curriculum development, T32, K, conference, and R01 routes.

5 Route Choices Before Drafting

Within 21 days, compare 5 routes.

RouteBetter first read when...Why
PA-27-034 courses trackCourse can run and build cancer research skillsRoute fits; replaces PAR-23-276
PA-27-034 curriculum or methods trackCurriculum or methods need development firstReplaces PAR-23-278; NCI caps it at $150,000 a year for 2 years
T32 or F/KFormal trainee support is centralTraining route may fit
R13 conferenceMeeting is the productConference route may fit
R01Research question is centralEducation route may be wrong

The strongest R25 applications make the educational product and learner outcome obvious.

6 Bad-Fit Signals

First, the project is mainly research. Second, the course cannot operate in year one. Third, the audience is not defined.

Fourth, evaluation is weak. Fifth, the activity includes a clinical trial. Sixth, the work is a conference or formal degree program rather than a course for skills development.

Those stop checks help users avoid treating R25 as a flexible bucket for any education idea.

21-Day R25 Readiness Plan

Days 1 through 3 should confirm you're applying to PA-27-034, not the expired PAR-23-276, and check source status, deadline, clinical-trial-not-allowed status, audience, and course type. Days 4 through 7 should build the curriculum map.

Days 8 through 12 should write the participant plan and faculty plan. Days 13 through 16 should build evaluation and follow-up metrics. Days 17 through 21 should compare R25 courses, R25 curriculum, T, K, F, conference, and research routes.

5 Readiness Signals to Check Before Drafting

Within 21 days, check 5 readiness signals. Signal 1 is course fit: the core product should be a course, workshop, short course, or similar skills-development activity.

Signal 2 is launch fit: the course should be ready enough to operate early, not spend the full project period in development.

Signal 3 is participant fit: the audience, prerequisites, selection, cohort size, and expected research role should be explicit.

Signal 4 is evaluation fit: skill demonstration, work products, follow-up, and research outputs should matter more than satisfaction alone.

Signal 5 is budget fit: participant costs belong in the Participant/Trainee Support Costs section, PAR-23-276 capped course-related participant expenses at $500 and per diem at $300 per day, and it didn't allow costs for full-time participants supported for a continuous 12-month period. Check PA-27-034 for its current participant-cost rules before you price the course.

5 Final Research Checks Before Submission

Within 21 days, finish 5 final research checks. Check 1 is the course model. The applicant should be able to describe who attends, what they practice, what they produce, and how skills will be assessed. If the activity is mostly a conference, this isn't the right page to follow.

Check 2 is cancer research fit. A course about data, communication, supportive care, methods, or community work can fit only when the cancer research use is plain. The guide should keep pushing users to state which cancer research skill changes and why NCI is the right home.

Check 3 is launch readiness. Some course teams spend the whole project period building the product. PAR-23-276 is stronger when the course can operate early, learn from participants, and improve in later cycles.

Check 4 is participant support. Salary, stipends, trainee support, and educational experiences can create confusion. It's better to check this early than to design a budget around assumptions that do not hold.

Check 5 is the route memo. You're ready to draft only when the team can say why this is R25 courses, not R25 curriculum development, T32, K award, R13 conference, R01, or internal training funds. Write that route memo before anyone builds the budget.

Before each cycle, recheck PA-27-034 and the NCI R25 page for notices that change dates or budgets. NCI expired three education notices at once in June 2026 with no advance date, so an internal summary written earlier in the year may still point to PAR-23-276. If the learner group, course modules, faculty roles, evaluation plan, and cancer research use aren't clear yet, do a course-readiness rewrite before the budget is built.

Sources

Largest awards active in FY2024

One row per recipient, its largest award | 2,179 Assistance Listing records | Avg: $1.0M

REAL DATA
1

Baylor College of Medicine

TX

$42.8M
2

Regents of the University of California, San Francisco, the

CA

$39.3M

Use the visible recipient rows as free source context

This program has no reviewed paid report today.

No reviewed paid report is currently offered for this program. The visible source rows remain free.

Next steps

Where to go next

These next pages help you move from research into a specific grant choice.

Frequently Asked Questions

What does PAR-23-276 fund?

It funded NCI R25 courses for skills development in cancer research. NCI expired it early on June 18, 2026 (NOT-CA-26-017). New NCI course applications now go through the parent R25, PA-27-034.

Are clinical trials allowed?

No. PAR-23-276 was clinical trial not allowed, and so is its replacement route, PA-27-034.

What kinds of activities fit?

Courses, workshops, short courses, and related research education activities that build skills for cancer research can fit.

What should applicants compare?

PAR-23-276 has expired, so compare the parent R25 course route (PA-27-034) with NCI R25 curriculum or methods development, training grants, conference routes, and standard research mechanisms.

Who should skip this route?

Skip it if the main product is research, a clinical trial, a conference, or curriculum development that cannot launch as a course in year one.

Last updated October 12, 2026. Corrected October 13, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.